Top 11 CRISPR Stocks To Invest In
Genome editing refers to a set of technologies enabling scientists to modify an organism's DNA by adding, removing, or altering genetic material at specific locations in the genome, as defined by MedlinePlus...
Beam Therapeutics Inc. (BEAM)
Market is closed
News
- 1 - 10
- Next >>
11 Most Promising Biotech Stocks to Buy According to Analysts
In this article, we will take a look at the 11 most promising biotech stocks to buy according to analysts.
14 Best Short-Term Stocks to Invest In
In this article, we will take a look at 14 best short-term stocks to invest in.
Top 20 Genomics Companies in the World
In this piece, we will take a look at the top 20 genomics companies in the world.
10 Stocks That Could 10X Over the Next 10 Years
In this article, we will be taking a look at 10 stocks that could 10x over the next 10 years.
12 Gene Editing Stocks With the Best Long-Term Potential
In this article, we will take a look at the 12 gene editing stocks with the best long-term potential.
Top 10 CRISPR Stocks To Buy
Molecular biology, genetics, and genomics are in a significant period in history where technical capabilities and methods enable the editing of specific DNA segments and base pairs in living organisms...
11 Most Promising Gene Editing Stocks According to Analysts
In this article, we will take a look at the 11 most promising gene editing stocks according to analysts.
15 Most Shorted Stocks Right Now on Wall Street
Short selling is a way for traders to make money by betting that the price of a stock will go down.
10 Most Promising Biotech Stocks According to Analysts
Last year was a period of transition for biotech firms.
- 1 - 10
- Next >>
Billionaire Hedge Funds
